Your browser of choice has not been tested for use with Barchart.com. If you have issues, please download one of the browsers listed here.
Join Barchart Premier to get Screeners that run automatically with the results emailed to you! FREE 30 Day Trial
Stocks | Futures | Watchlist | More
or

Marizyme Inc (MRZM)

Marizyme Inc (MRZM)
[[ item.lastPrice ]] [[ item.priceChange ]] ([[ item.percentChange ]]) [[ item.tradeTime ]] [OTC US]
[[ item.bidPrice ]] x [[ item.bidSize ]] [[ item.askPrice ]] x [[ item.askSize ]]
[[ session ]] by (Cboe BZX)
[[ item.lastPrice ]] [[ item.priceChange ]] ([[ item.percentChange ]]) [[ item.tradeTime ]] [OTC US]
[[ item.bidPrice ]] x [[ item.bidSize ]] [[ item.askPrice ]] x [[ item.askSize ]]
[[ session ]] [[ item.lastPriceExt ]] [[ item.priceChangeExt ]] ([[ item.percentChangeExt ]]) [[ item.tradeTimeExt ]]
Quote Overview for [[ item.sessionDateDisplayLong ]]
[[ rowChartData.labelLow ]]
[[ rowChartData.lowPriceFormatted ]]
[[ rowChartData.lowPrice ]]
[[ rowChartData.labelHigh ]]
[[ rowChartData.highPriceFormatted ]]
[[ rowChartData.highPrice ]]
since [[ rowChartData.lowDate ]]
since [[ rowChartData.highDate ]]
[[ value ]] [[ value ]]

Fundamentals

See More
  • Market Capitalization, $K N/A
  • Shares Outstanding, K N/A
  • Annual Sales, $ 210 K
  • Annual Income, $ -10,998 K
  • 60-Month Beta N/A
  • Price/Sales 776.17
  • Price/Cash Flow N/A
  • Price/Book N/A
Trade MRZM with:
  • Price/Earnings ttm N/A
  • Earnings Per Share ttm N/A
  • Most Recent Earnings N/A on N/A
  • Latest Earnings Date N/A
  • Annual Dividend & Yield N/A (N/A)
  • Most Recent Dividend N/A on N/A
  • Sectors:

Price Performance

See More
Period Period Low Period High Performance
1-Month
0.0650 +36.00%
on 03/15/24
0.1339 -33.98%
on 03/21/24
-0.0126 (-12.48%)
since 02/27/24
3-Month
0.0650 +36.00%
on 03/15/24
0.1339 -33.98%
on 03/21/24
-0.0616 (-41.07%)
since 12/21/23
52-Week
0.0500 +76.80%
on 07/07/23
0.4050 -78.17%
on 10/06/23
-0.3115 (-77.89%)
since 03/17/23

Most Recent Stories

More News
Marizyme (OTCQB: MRZM) Announces IP Developments for DuraGraft and Its Pipeline Products

JUPITER, FL, May 10, 2023 (GLOBE NEWSWIRE) -- via NewMediaWire – Marizyme, Inc. ("Marizyme" or the "Company") (OTCQB: MRZM), a

MRZM : 0.0884 (-6.95%)
Marizyme (OTCQB: MRZM) CEO Delivers Business Update

JUPITER, FL, May 03, 2023 (GLOBE NEWSWIRE) -- via NewMediaWire – Marizyme, Inc. ("Marizyme" or the "Company") (OTCQB: MRZM), today

MRZM : 0.0884 (-6.95%)
Marizyme Announces Allowance of Patent Application for Flagship Product DuraGraft by United States Patent and Trademark Office

Jupiter, FL, Jan. 05, 2022 (GLOBE NEWSWIRE) -- via NewMediaWire -- Marizyme, Inc. (“Marizyme” or the “Company”) (OTCQB: MRZM) is pleased to announce that...

MRZM : 0.0884 (-6.95%)
Marizyme Announces the Closing of My Health Logic Acquisition Along With Initial Financing

JUPITER, Fla., Dec. 23, 2021 (GLOBE NEWSWIRE) -- via NewMediaWire -- Marizyme Inc. (“Marizyme” or the “Company”) (OTCQB:MRZM), is pleased to announce the...

MRZM : 0.0884 (-6.95%)
CHIP-H.VN : 0.050 (unch)
Marizyme Inc. Announces Results of GOAL Study Presented at 7th Annual International Coronary Congress

JUPITER, FL, Dec. 03, 2021 (GLOBE NEWSWIRE) -- via NewMediaWire – Marizyme Inc. (MRZM), a biotechnology company engaged in the development and...

MRZM : 0.0884 (-6.95%)
Marizyme Announces Expansion of Patent Portfolio Into Several Key Territories

Jupiter, FL, Dec. 03, 2021 (GLOBE NEWSWIRE) -- via NewMediaWire -- Marizyme Inc. (MRZM), a biotechnology company engaged in the development and...

MRZM : 0.0884 (-6.95%)
Marizyme is Pleased to Announce the Appointment of David Barthel as CEO

JUPITER, Fla., Nov. 16, 2021 (GLOBE NEWSWIRE) -- via NewMediaWire -- Marizyme Inc. (“Marizyme” or the “Company”) (OTCQB:MRZM), is pleased to announce the...

MRZM : 0.0884 (-6.95%)
Marizyme and SBH Nutrition Science Agree to Develop Krillase(R) Based Dental Products for Pets

JUPITER, FL / ACCESSWIRE / October 27, 2020 /Marizyme, Inc. (OTCQB:MRZM) ("Marizyme" or the "Company"), an integrated life sciences company, announced today that it has signed a binding letter of intent...

MRZM : 0.0884 (-6.95%)
Marizyme Announces European DuraGraft(R) Registry Results Presented at the European Association for Cardio-Thoracic Surgery (EACTS) 34th Annual Virtual Meeting

JUPITER, FL / ACCESSWIRE / October 9, 2020 / Marizyme, Inc. ("Marizyme" or the "Company") (OTCQB:MRZM) is a global biotechnology company developing products to reduce the burden of ischemia-reperfusion...

MRZM : 0.0884 (-6.95%)
BioMedNewsBreaks – Marizyme Inc. (MRZM) Closes Acquisition of Somulation Inc., $7M Private Placement

Marizyme (OTC: MRZM), a client of Univest Securities LLC, a full-service investment bank and securities broker-dealer firm and a member of FINRA and SIPC, recently closed the acquisition of Somulation...

MRZM : 0.0884 (-6.95%)

Barchart Technical Opinion

The Barchart Technical Opinion rating is a 100% Sell with a Strengthening short term outlook on maintaining the current direction.

Long term indicators fully support a continuation of the trend.

See More Share

Key Turning Points

3rd Resistance Point 0.0884
2nd Resistance Point 0.0884
1st Resistance Point 0.0884
Last Price 0.0884
1st Support Level 0.0884
2nd Support Level 0.0884
3rd Support Level 0.0884

See More

52-Week High 0.4050
Fibonacci 61.8% 0.2694
Fibonacci 50% 0.2275
Fibonacci 38.2% 0.1856
Last Price 0.0884
52-Week Low 0.0500

See More

Want to use this as
your default charts setting?
Save this setup as a Chart Templates
Switch the Market flag
for targeted data from your country of choice.
Open the menu and switch the
Market flag for targeted data from your country of choice.
Want Streaming Chart Updates?
Switch your Site Preferences
to use Interactive Charts
Need More Chart Options?
Right-click on the chart to open the Interactive Chart menu.

Free Barchart Webinar